Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Immunotech Biopharm Ltd ( (HK:6978) ) has shared an update.
Immunotech Biopharm Ltd has announced that its board of directors will meet on March 28, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. This meeting is crucial as it will determine the financial performance of the company and could influence its market positioning and stakeholder confidence.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a biotechnology company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative biopharmaceutical products. The company operates within the pharmaceutical industry, with a market focus on developing treatments and therapies for various medical conditions.
YTD Price Performance: 87.39%
Average Trading Volume: 611,035
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$2.43B
For an in-depth examination of 6978 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue